首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Essential fatty acid deficiency in patients receiving home parenteral nutrition.
【24h】

Essential fatty acid deficiency in patients receiving home parenteral nutrition.

机译:接受家庭肠胃外营养的患者体内必需脂肪酸缺乏。

获取原文
获取原文并翻译 | 示例
           

摘要

Home parenteral nutrition (HPN), initiated in patients with severe malabsorption or decreased oral intake, may exhaust stores of essential fatty acids and cause clinical manifestations, mainly dermatitis. Plasma fatty acid profiles were measured by gas-liquid chromatography in 37 healthy control subjects and 56 patients receiving HPN. The concentration (% by wt of total fatty acids) of 18:2n-6 was 22.8% and 11.4% (P < 0.001), whereas 18:3n-3 was 0.2% and 0.1% (P < 0.01) in control subjects and patients, respectively. Reduced small bowel length was associated with aggravated biochemical signs of essential fatty acid deficiency (EFAD). The effect of parenteral lipid on plasma phospholipids was evaluated in subgroups of patients. In patients with > 200 cm of remaining small intestine, those receiving parenteral lipids had only minor changes in the fatty acids of plasma phospholipids compared with patients not receiving parenteral lipids. In patients with < 100 cm of remaining small intestine, those receiving parenteral lipids had increased concentrations of total n-6 fatty acids; however, these did not reach the concentrations in control subjects. No differences were seen in n-3 fatty acids. Twenty-five of the 56 patients receiving HPN reported skin problems. No differences were found in plasma phospholipid fatty acids, Holman index, or the supply of parenteral lipids between patients with and without skin problems. Patients receiving HPN had biochemical signs of EFAD. Parenteral lipids did not increase the concentration of essential fatty acids to values comparable with those of control subjects, but 500 mL 20% Intralipid once a week was sufficient to prevent an increase in the Holman index above 0.2.
机译:严重吸收不良或口腔摄入减少的患者开始的家庭肠胃外营养(HPN)可能会耗尽必需脂肪酸,并导致临床表现,主要是皮炎。通过气液色谱法在37名健康对照受试者和56名接受HPN的患者中测定了血浆脂肪酸谱。在对照组和对照组中,18:2n-6的浓度(以总脂肪酸的重量百分比计)分别为22.8%和11.4%(P <0.001),而18:3n-3的浓度分别为0.2%和0.1%(P <0.01)。病人。小肠长度减少与必需脂肪酸缺乏症(EFAD)的生化迹象加重有关。在患者亚组中评估了肠胃外脂质对血浆磷脂的影响。在剩余小肠面积大于200 cm的患者中,与不接受肠胃外脂质的患者相比,接受肠胃外脂质的患者血浆磷脂的脂肪酸变化很小。在剩余小肠小于100 cm的患者中,接受肠胃外脂质治疗的患者的总n-6脂肪酸浓度增加;然而,这些没有达到对照受试者的浓度。在n-3脂肪酸中未见差异。在接受HPN的56例患者中,有25例报告了皮肤问题。在有和没有皮肤问题的患者之间,血浆磷脂脂肪酸,Holman指数或肠胃外脂质供应均无差异。接受HPN的患者有EFAD的生化征象。肠胃外脂质并未将必需脂肪酸的浓度增加到与对照组受试者相当的水平,但每周一次500 mL 20%的Intralipid足以防止Holman指数升高至0.2以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号